Related Experiment Video
Updated: Jul 1, 2026

Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Published on: January 14, 2020
[Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?]
1II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München.
Abstract:
Despite the advances in the knowledge of the molecular pathogenesis, pancreatic cancer remains a devastating disease with an 5-year survival rate below 5%. Current therapeutic approaches are not successful in respect to overall survival. There is a need to transfer the knowledge of basic science to new therapeutic strategies. This review describes the disturbed cell cycle control, anti-apoptotic mechanisms, the process of invasion and metastasis and angioneogenesis of pancreatic cancer cells. This knowledge will allow the development of novel therapeutic strategies for the future.
Insights
Pancreatic cancer has poor survival rates despite molecular advances. This review details cancer cell cycle, apoptosis, invasion, and angiogenesis to guide new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Context:
- Pancreatic cancer has a dismal 5-year survival rate (<5%) despite progress in understanding its molecular pathogenesis.
- Current treatments for pancreatic cancer are largely ineffective in improving overall survival.
- A significant gap exists between basic science discoveries and their translation into effective therapeutic strategies.
Purpose:
- To review the key molecular mechanisms driving pancreatic cancer progression.
- To elucidate disturbed cell cycle control, anti-apoptotic pathways, invasion, metastasis, and angiogenesis in pancreatic cancer.
- To provide a foundation for developing novel therapeutic interventions.
Summary:
- This review examines critical molecular alterations in pancreatic cancer, including dysregulated cell cycle control, evasion of apoptosis, and promotion of invasion, metastasis, and angiogenesis.
- Understanding these fundamental processes is crucial for identifying new therapeutic targets.
- The review synthesizes current knowledge on the molecular pathogenesis of pancreatic cancer.
Impact:
- Facilitates the development of innovative therapeutic strategies for pancreatic cancer.
- Aims to improve treatment outcomes and patient survival rates.
- Bridges the gap between basic research and clinical application in pancreatic cancer therapy.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology

